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Background: The changing trend of GI disorders has not been expounded in our setting, 
there is need to examine the extent to which major endoscopically diagnosed upper GI 
disorders have changed in the last 10 years (2005 to 2015). 
Methods: This was a retrospective study in which endoscopically diagnosed GI disorders of 
Jan-Jun 2005 were compared with 2015 (10 years) for the same period 
Results: In the 10 years (2005 to 2015), the prevalence of peptic ulcer disease (PUD) 
reduced from 9.6% to 2.9% (P value 0.000), followed by esophageal varices from 10.3% to 
4.0%, and duodenitis from 3.2% to 0.7% respectively. Gastritis increased from 18.4% to 
48.2% (P value 0.000), followed by cancer esophagus from 3.2% to 5.1%.  
Conclusion: As the prevalence of PUD decreases in our community, gastritis increases hence 
patients with upper GI symptoms tend to suffer gastritis thus clinicians should focus on 
treating gastritis and eradication of Helicobacter pylori. 
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Introduction 
Upper Gastrointestinal (GI) endoscopies are often used to confirm diagnosis in patients with 
gastrointestinal symptoms. Results from endoscopic exam allow association of 
esophagogastroduodenal (EGDS) findings with patient presentation and extrapolation of the 
findings to patient population in clinical practice1. Endoscopically diagnosed disorders tend to 
vary although Peptic ulcer disease (PUD) has remained a relatively common condition 
worldwide, with annual incidence ranging from 0.10% to 0.19%2. However in Canada, PUD 
comprises 7.5% of the GI disorders, followed by celiac disease (2.5%)3. In Togo, the prevalence 
of PUD is 34.2%, followed by esophagitis, gastritis, bulboduodenitis combined (32.4%) and 
esophageal varicosities (3.7%)4. In Uganda Okello (2006)5 found PUD prevalence of 14.8% 
followed by gastritis (12.6%), and duodenitis (4.4%) but in Kenya gastritis is the most common 
EGDS lesion (25.8%)6. However, the trend of common upper GI disorders over the last 10 years 
period is not yet known in our environment.  
Many studies in different research environment and setting have noted a reduction in PUD 
prevalence and incidence as well as significant changes in other GI disorders overtime2. For 
example the incidence PUD in Finland reduced by 89% within 10 yrs from 1987 to 1997.7 This is 
attributable to the introduction of modern anti-secretory drugs, histamine2-receptor 
antagonists and proton-pump inhibitors (PPI) as well as eradication therapy of Helicobacter 
pylori and change in life style.. Since we lack evidence of the changing trends of upper GI 
disorders in our community, clinicians have continued to diagnose and treat for PUD on nearly 
all patients who present with epigastralgia and/or dyspeptic symptoms hence the need to do a 
10 years trend/comparison of upper GI lesions found at endoscopy.  
 The main objective of this study was to determine the extent to which major endoscopically 
diagnosed upper GI disorders have changed in the last 10 years (2005 to 2015). 
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 Patients and Methods  
 
A retrospective review of patients’ records covering January to June for both 2005 and 2015 
was  performed. It included all cases of upper GI endoscopy done at St Mary’s Hospital Lacor, a 
large rural based University teaching general hospital with 483 beds, located in Northern 
Uganda. Currently the Hospital has two general surgeons who perform over 24 upper GI 
endoscopy per week and each of the surgeons has over 10 years experience in EGDS. All 
patients who undergo endoscopy have to give inform consent on the day of scoping prior to the 
procedure, however their consent was not necessary for this study. The main endoscopy 
findings that were examined in the study consisted of PUD, Gastritis and other GI disorders. 
Overall, the following variables were obtained and analysed using SPSS version 15 to determine 
the trend prevalence from 2005 and 2015: age, gender, outpatient diagnosis, endoscopy 
findings, histology findings, presence of malignant cancer. 
 
Results 
Within the study period Jan – Jun 2005 a total of n=282 patients underwent upper GI 
endoscopic examination, whereas in 2015, approximately n=581 had the procedure with the 
same period.  
In 2005, the mean age of patients undergoing endoscopic exam was 36.997 yrs (SD +/- 13.8628) 
while in 2015, the mean age was 39.99yrs (SD +/- 16.169). When compared, the patients who 
had endoscopic exam in 2015 were significantly older than those who were examined by the 
same procedure in 2005 (P-value 0.013) (Table 1).  
In comparison, within the age groups of children (0-11yrs), 0.7% had upper GI endoscopy in 
2015, but none (0%) in 2005; 5% of the adolescents (11-18yrs) had upper GI endoscopy in 
2005, while 6.9% in 2015; 50.7% of the young adults (19-35yrs) had the procedure in 2005 and 
38.2% in 2015. Adults (36-65yrs) in 2005 accounted for 41.1%, compared to 46.6% in 2015. Of 
the elderly (>66yrs), 3.2% received upper GI scoping in 2005, compared to 6.9% in 2015 (Table 
1). Therefore it can be inferred that within the same age group, more patients were examined in 
2015 compared with 2005. However, on comparison of the age groups between the two study 
periods, there were significantly more patients in 2015 than 2005 (P value 0.009) (Table 1). 
Prevalence of PUD in 2005 vs 2015 
Out of the positive upper endoscopy findings, the prevalence of PUD in 2005 was compared 
with that of 2015 (Table 2). The prevalence of PUD was found to be 9.6% in 2005 and, in 
comparison, it had fallen to 2.9% by 2015. When statistically tested, the prevalence of PUD 
significantly reduced within 10 years in our community (Odds ratio (OR) =4.69 (95% CI), Chi-
square 48.78 and P value 0.0000).  
Table 1. Age at Endoscopy Procedure 2005 vs 2015 
  
Age Group 
2005  2015 
Frequency Percent 
(%) 
 Frequency Percent (%) 
Children (0-10yrs) 0 0  4 0.7 
Adolescents (11-
18Yrs) 
14 5.0  42 6.9 
Youth (19-35yrs) 143 50.7  235 38.8 
Adults (36-65yrs) 116 41.1  282 46.6 
Elderly (>66yrs) 9 3.2  42 6.9 
Total 282 100  605 100 
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Table 2. Prevalence of PUD in 2005 vs 2015 
  
Positive Endoscopy 
Endoscopy 2005   Endoscopy 2015 
Frequency Percent Frequency Percent 
PUD 17 9.6 14 2.2 
Non PUD 161 90.4 473 97.1 
Total 178 100 487 100 
 
Gastritis in 2005 vs 2015 
From Table 3, in 2005 approximately 36.9% (n=282) of the upper GI scopes were found to be 
normal, but by 2015, the proportion of normal scopes had fallen to only 19.5% (n=581). 
Amongst the positive endoscopy findings, the rate of gastritis in comparison to other lesions, 
significantly increased from 18.4% in 2005 to 48.2% in 2015 (Odds ratio 3.57, Relative risk 
2.08, Chi-square 130.95, P value < 0.001. Therefore since 2005, the prevalence of gastritis 
increased by more than two and a half time in the last 10 years, such that in our community, the 
majority of persons with gastrointestinal symptoms are suffering gastritis.  
Other Upper GI Lesions in 2005 vs 2015 
In Table 4, the following lesions have reduced in prevalence between 2005 and 2015: 
esophageal varices from 10.3% to 4.0%, followed by duodenitis from 3.2% to 0.7% and 
deformed duodenal bulb from 1.8% to 0.5%, respectively. On the other hand, cancer of the 
esophagus have exhibited an increase in its prevalence, from 3.2% to 5.1%, in the last 10 years 
(2005 and 2015); while esophagitis remained stable between the two study periods.  
Table 3. Prevalence of Gastritis in 2005 vs 2015 
 2005 2015 
  Frequency Percent Frequency Percent 
Other lesion 126 44.7 187 32.2 
Gastritis 52 18.4 280 48.2 
Normal 104 36.9 114 19.6 
Total 282 100 581 100 
 
Table 4: Other GI Lesions Upper in 2005 vs 2015                      
Endoscopy findings 2005 (=282)  Endoscopy findings 2015 (n=581)    
 GI Disorder Frequenc
y 
%  GI Disorder   Frequency % 
Esophagitis 29 10.3 Esophagitis 79 13.3% 
Esophageal 
varices 
29 10.3 Esophageal varices 23 4.0% 
Duodenitis 9 3.2 Duodenitis 4 0.7% 
Ca esophagus 9 3.2 Ca esophagus 31 5.1% 
Ca stomach 1 0.4 Ca stomach 6 1.0% 
Hiatus Hernia 17 6.0 Hiatus Hernia 6 1.0% 
Deformed 
duodenal bulb 
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Discussion 
This study which compared a 10year trend of the various upper GI lesions in 2005 and 2015 
tended to elucidate changes in prevalence of PUD, gastritis and other common GI disorders. The 
study found significant difference in the mean age of upper GI endoscopy patients in the last 10 
years (2005-2015): 36.997 yrs in 2005 vs 39.99 yrs in 2015 (P value 0.013). Whereas a study in 
Ethiopia by Taye and coll.8 in 2004 found that the mean age of the patients with GI disorders 
requiring endoscopy was 36 years, recent studies9 (2015) have found a mean age of patients 
needing endoscopy to be 39.7 years, which is congruent to what this study found in the same 
time periods. Furthermore, there was a tendency for patients with upper GI disorder requiring 
endoscopy to be older in 2015 compared to 2005 (P value 0.009). This perhaps relates to the 
decreasing mortality rate as well as the improving life expectancy in our community. According 
to the World Bank, life expectancy improved in northern Uganda from 47.9 to 53.6 yrs between 
1990 to 2014 and mortality reduced from 526.0 to 400.0 in the same time period10. 
Furthermore, the return of peace in our society led to re-opening of many health facilities hence 
improving access and patients only came for endoscopy after several symptomatic and 
empirical treatment.  
The prevalence of PUD significantly reduced from 9.6% to 2.9% in 10 years (2005 to 2015) 
[Odds ratio = 4.69 (95% CI), Chi-square 48.78 and P value 0.0000]. This finding is congruent 
with a meta-analysis report of global literature, which showed that the incidence and 
prevalence of PUD have decreased over time in recent decades2.  In Finland, a study found the 
introduction of modern anti-secretory drugs, histamine2-receptor antagonists and proton-
pump inhibitors as well as eradication therapy of Helicobacter pylori, to have led to reduced 
incidence of surgery, hospital admissions and mortality for PUD by 89% within 10yrs (1987-
1997)7 Furthermore in the USA, hospitalization for PUD significantly reduced from 
71.1/100,000 population (95% confidence interval [CI] 68.9–73.4) to 56.5/100,000 (95% CI 
54.6–58.3) between 1998 to 200511.  Similarly, Sweden also reported a significant reduction in 
PUD, the causes of which includes change in smoking habits, Non Steroidal Anti-inflammatory 
Drugs [NSAID] consumption, reducing prevalence of Helicobacter pylori and the introduction of 
PPI12. The reduced incidence and prevalence of PUD has implication for clinicians and their 
prescription of anti-ulcer medication. 
 
The rate of gastritis has however increased in our community two and a half folds in the last 10 
years from 18.4% in 2005 to 48.2% in 2015 (Odds ratio 3.57, Relative risk 2.08, Chi-square 
130.95, P value < 0.001). In 2006, Okello5 in 2006 also found a low gastritis rate of 12.6% and in 
a recent study (2016), Okello et al9 found a gastritis rate of 47.9% and it was the commonest 
condition affecting gastrointestinal patients. Japan also reported an increase in gastritis rate 
from 9.4% to over 70% and this was strongly associated with Helicobacter pylori infection13.  
Whereas Okello et al in 20169 found Helicobacter pylori infection rate of 53% in patients with 
gastritis, Gherasim and Dranga14 attributed high rate of gastritis in their study to chronic alcohol 
consumption in Romania. In India, by 2013, a study reported that acute or chronic gastritis are 
caused by risk factors such as smoking, alcohol consumption, tobacco use, spicy food, drugs, 
stress, swallowed foreign bodies and bacterial infection, mainly Helicobacter pylori15. Cigarette 
smoking, poor sanitation, and lack of formal education are known significant predisposing 
factors to Helicobacter pylori infection16.  Furthermore, gastritis itself impedes and make it more 
difficult to eradicate the bacteria, and the difficulty increases with the severity of  
Helicobacter pylori 17 Our community in the north of Uganda has remained underdeveloped, 
with poverty level of 43.3% compared to the national average of 19.7%18. A combination or all 
these factors are perhaps increasing the rate of gastritis in our community. 
Cancer of the esophagus has exhibited an increase in its prevalence between 2005 and 2015, 
from 3.2% to 5.1%. Other researchers working independently also found an accelerated 
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increase in the incidence and prevalence of esophageal cancer in USA and Norway, 
respectively19, 20. Our community which has high rates of poverty, poor nutrition and consumes 
concentrated crude spirits, could one time become a hub of esophageal cancer. However, within 
the same time period, other upper GI disorders like duodenitis, esophageal varices have 
demonstrated a downward trend, while esophagitis has remained stable. It is not yet clear 
whether the wide spread use of PPI currently available Over The Counter (OTC), as well as 
better ultrasonic diagnosis of portal hypertension and treatment, together with the renewed 
campaign against Hepatitis B infection in our environment is contributing to these reduction.  
Conclusions:  
In the last 10 years (2005 to 2015), PUD prevalence has significantly decreased in our 
community from 9.6 to 2.9% as well as duodenitis, deformed duodenal bulb, and esophageal 
varices. However, within the same period, gastritis and cancer of the esophagus rates have 
increased in our environment from 18.4% to 48.2% and 3.2% to 5.1%, respectively.  
Recommendation 
Clinician practicing in our setting should focus on treating gastritis and eradication of 
Helicobacter pylori in patients with upper GI symptoms. Nonetheless, an in-depth study in 
patients with gastritis should be considered.   
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